Last reviewed · How we verify
HRS-8427 injection plus metformin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HRS-8427 injection plus metformin (HRS-8427 injection plus metformin) — Jiangsu HengRui Medicine Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HRS-8427 injection plus metformin TARGET | HRS-8427 injection plus metformin | Jiangsu HengRui Medicine Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HRS-8427 injection plus metformin CI watch — RSS
- HRS-8427 injection plus metformin CI watch — Atom
- HRS-8427 injection plus metformin CI watch — JSON
- HRS-8427 injection plus metformin alone — RSS
Cite this brief
Drug Landscape (2026). HRS-8427 injection plus metformin — Competitive Intelligence Brief. https://druglandscape.com/ci/hrs-8427-injection-plus-metformin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab